Libri Psicofarmacologia: Novità e Ultime Uscite
Vai al contenuto della pagina
Dal 1946 a fianco di professionisti e studenti Scopri cosa dicono di noi

Psicofarmacologia

The Maudsley Deprescribing Guidelines

Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs

David M. Taylor, Mark Horowitz

editore: Wiley-Blackwell

pagine: 592

The Maudsley® Deprescribing Guidelines Comprehensive resource describing guidelines for safely reducing or stopping (deprescribing) antidepressants, benzodiazepines, gabapentinoids and z-drugs for patients, including step-by-step guidance for all commonly used medications, covering common pitfalls, troubleshooting, supportive strategies, and more. Most formal guidance on psychiatric medication relates to starting or switching medications with minimal guidance on deprescribing medication. In 2023, the World Health Organisation and the United Nations called for patients, as a human right, to be informed of their right to discontinue treatment and to receive support to do so. The Maudsley Deprescribing Guidelines fills a significant gap in guidance for clinicians by providing comprehensive and authoritative information on this important aspect of treatment. This evidence-based handbook provides an overview of principles to be used in deprescribing. This is derived from fundamental scientific principles and the latest research on this topic, combined with emerging insights from clinical practice (including from patient experts). Building on the recognised brand of The Maudsley Prescribing Guidelines, and the prominence of the authors’ work, including in The Lancet Psychiatry on tapering antidepressants (the most read article across all Lancet titles when it was released). The Maudsley Deprescribing Guidelines covers topics such as: Why and when to deprescribe antidepressants, benzodiazepines, gabapentinoids and z-drugs Barriers and enablers to deprescribing including physical dependence, social circumstances, and knowledge about the discontinuation process Distinguishing withdrawal symptoms, such as poor mood, anxiety, insomnia, and a variety of physical symptoms from symptoms of the underlying disorder that medication was intended to treat The difference between physical dependence and addiction/substance use disorder Explanation of why and how to implement hyperbolic tapering in clinical practice Specific guidance on formulations of medication and techniques for making gradual reductions, including using liquid forms of medication, and other approaches Step-by-step guidance for safely stopping all commonly used antidepressants, benzodiazepines, gabapentinoids and z-drugs, including fast, moderate and slow tapering regimens or schedules for each drug, and guidance on how to tailor these to an individual Troubleshooting issues which can arise on stopping these medications, including akathisia, withdrawal symptoms, acute or protracted, and relapse. Written for anyone interested in safe deprescribing of psychiatric medications including psychiatrists, GPs, pharmacists, nurses, medical trainees, and interested members of the public. The Maudsley Deprescribing Guidelines is an essential resource on the subject that provides practical guidance on how to improve patient outcomes in this field of medicine.
31,00 29,45

Tutto quello che vorreste sapere sulle nuove sostanze psicoattive e non avete trovato da nessuna parte

Emanuele Bignamini, Amir Garofalo

editore: Giovanni Fioriti Editore

pagine: 184

Questo libro esplora il mondo delle nuove sostanze psicoattive dal punto di vista clinico, farmacologico e fenomenico
20,00 19,00

Maudsley. Linee Guida alla Prescrizione in Psichiatria

David M. Taylor, Thomas R. E. Barnes
e altri

editore: Piccin-Nuova Libraria

pagine: 1016

PrefazioneLa 14esima edizione delle Linee Guida è stata scritta nel corso del verificarsi di una circostanza straordinaria: la pandemia da coronavirus. Questo fenomeno globale ha modificato radicalmente le vite e le pratiche lavorative di miliardi di persone e la maggior parte di noi, oggi, ha conosciuto, personalmente o indirettamente, la grave malattia fisica associata al COVID-19. Ad esserne particolarmente colpiti sono stati gli operatori sanitari che si trovano ad essere a contatto con quanti si sono ammalati, rischiando essi stessi di contrarre l’infezione. In un simile contesto, la stesura di un libro ha una priorità estremamente bassa, se non addirittura nulla. È tenendo conto di ciò che rivolgo il mio più vivo e sincero ringraziamento a tutti coloro che hanno contribuito alla realizzazione di questa edizione delle Linee Guida in condizioni così difficili. Naturalmente, durante la pandemia, i problemi di salute mentale non sono scomparsi e il trattamento ottimale delle malattie mentali rimane un imperativo vitale. Tale obiettivo diventa ancora più importante quando affrontiamo le conseguenze della pandemia. Questa edizione delle Linee Guida è stata accuratamente aggiornata ed include le ricerche più influenti pubblicate a partire dal 2017 e tutti i principali farmaci psicotropi che sono stati da allora introdotti. Questa edizione prevede inoltre nuove sezioni dedicate a temi quali il delirium con agitazione, l’impiego dei farmaci psicotropi nei pazienti terminali, le formulazioni dei farmaci psicotropi da somministrare per via endovenosa, la somministrazione di clozapina per via intramuscolare e la somministrazione settimanale di penfluridolo per via orale. Come le precedenti, questa 14esima edizione è stata realizzata con l’intento di avere un’utilità a livello mondiale, pur avendo una certa influenza soprattutto nel Regno Unito. Vorrei rivolgere un ringraziamento particolare a Siobhan Gee per il meticoloso lavoro compiuto sull’impiego della clozapina, a Mark Horowitz per le indicazioni basate sull’evidenza e incentrate sul paziente in relazione alla cessazione della somministrazione dei farmaci psicotropi, a Delia Bishara, la quale si è occupata praticamente da sola del capitolo dedicato agli anziani e a Ian Osborne per il contributo fornito in relazione ad una gamma eccezionalmente ampia di temi. Un riconoscimento particolare merita Emily Finch per l’organizzazione della stesura del capitolo sulle dipendenze nelle ultime dieci edizioni del le Linee Guida. Infine voglio porgere il mio ringraziamento alla mia assistente Ivana Clark,  che ha contribuito alla realizzazione di questa edizione con pazienza e incomparabile attenzione al dettaglio. David M. TaylorLondraMarzo 2021
75,00 71,25

Psicofarmacologia della depressione

Marco A. Riva

editore: Minerva Medica

pagine: 144

31,00 29,45

Psicofarmacologia essenziale. Basi neuroscientifiche e applicazioni pratiche

Stephen M. Stahl

editore: Edi. Ermes

pagine: 664

L'opera è considerata da sempre il principale riferimento nel campo della neurofarmacologia
75,00 66,97

Come sospendere i farmaci antidepressivi. La gestione personalizzata delle sindromi da astinenza

Giovanni Andrea Fava

editore: Franco Angeli

pagine: 168

L'uso dei farmaci antidepressivi, soprattutto quelli di nuova generazione, è in continua crescita, sembra che almeno una perso
25,00

Psicofarmacologia essenziale. Guida alla prescrizione bambini e adolescenti

Stephen M. Stahl

editore: Edi. Ermes

pagine: 504

La psicofarmacologia del bambino e dell'adolescente è un campo in rapida espansione nel quale si utilizzano estesamente i farm
60,00 52,51

Case Studies: Stahl's Essential Psychopharmacology: Volume 3

a cura di Stephen Stahl, Takesha CooperGerald Maguire
e altri

editore: Cambridge University Press

pagine: 448

Following the success of the first two volumes in Stahl's Case Studies series, a brand new collection of clinical stories have been collated in Volume 3, derived from cases seen by medical students, residents and faculty from the University of California at Riverside (UCR) Department of Psychiatry and Neuroscience. The highly popular and unique user-friendly presentation of previous volumes has been maintained, with extensive use of icons, questions/answers, and tips. The cases address multifaceted issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way. The book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey. This is psychiatry in real life.
63,00 59,85

Stahl's Essential Psychopharmacology

Neuroscientific Basis and Practical Applications

Stephen M. Stahl

editore: Cambridge University Press

pagine: 644

Long established as the preeminent source in its field, the eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! With its use of icons and figures that form Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. Every aspect of the book has been updated, with the clarity of explanation that only Dr Stahl can bring. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, fourteen new uses for older drugs and eighteen brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy.
111,00 105,45

The Maudsley Prescribing Guidelines in Psychiatry

David M. Taylor, Thomas R. E. Barnes
e altri

editore: Wiley-Blackwell

pagine: 976

The Maudsley Prescribing Guidelines in Psychiatry The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe and effective prescribing of psychotropic agents. Covering both common and complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum and maximum doses, adverse effects, switching medications, prescribing for special patient groups, and more. Each clear and concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based. The fourteenth edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions, and all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand, and Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry: Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression and anxiety, borderline personality, eating disorders, and many others Provides advice on prescribing for children and adolescents, older people, pregnant women, and other special patient groups Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses, and dopamine super-sensitivity Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco, and caffeine, and treating patients with comorbid physical conditions Whether in the doctor's office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, Fourteenth Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses, and other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy, and nursing.
67,00 63,65

Practical Psychopharmacology

Translating Findings From Evidence-Based Trials into Real-World Clinical Practice

Stephen M. Stahl, Joseph F. Goldberg

editore: Cambridge University Press

pagine: 610

Despite the lack of guidance available for practitioners, extensive polypharmacy has become the primary method of treating patients with severe and chronic mood, anxiety, psychotic or behavioral disorders. This ground-breaking new book provides an overview of psychopharmacology knowledge and decision-making strategies, integrating findings from evidence-based trials with real-world clinical presentations. It adopts the approach and mind-set of a clinical investigator and reveals how prescribers can practice 'bespoke psychopharmacology', tailoring care to the individualized needs of patients. Practitioners at all levels of expertise will enhance their ability to devise rationale-based treatments, targeting manifestations of dysfunctional neural circuitry and dimensions of psychopathology that cut across conventional psychiatric diagnoses. Presented in a user-friendly, practical, full-colour layout and incorporating summary tables, bullet points, and illustrative case vignettes, it is an invaluable guide for all healthcare professionals prescribing psychotropic medications, including psychiatry specialists, primary care physicians, and advanced practice registered nurses.
65,00 61,00

Psicofarmacologia in oncologia e cure palliative. Manuale pratico di psicofarmacologia

a cura di L. Grassi, M. B. Riba

editore: Il Pensiero Scientifico

pagine: 536

La psicofarmacologia ha un ruolo molto importante tra gli interventi integrati per i disturbi psichici nelle persone affette d
60,00 57,00

Psicofarmacologia essenziale. Guida alla prescrizione

Stephen M. Stahl

editore: Edi. Ermes

La Guida alla prescrizione fornisce le informazioni pratiche sull’uso dei farmaci psicotropi – quelli in grado di agire sulle funzioni psichiche dell'individuo – utili nell’attività clinica quotidiana. La trattazione di ogni farmaco è suddivisa in cinque sezioni, ciascuna contraddistinta da uno specifico colore: Informazioni terapeutiche, Effetti collaterali, Posologia e modalità d’uso, Popolazioni speciali e Arte della psicofarmacologia. Quest’ultima sezione è dedicata alle opinioni dell’Autore su questioni come i potenziali vantaggi o svantaggi del farmaco, i principali sintomi bersaglio e una serie di notazioni cliniche che hanno lo scopo di ottimizzare l’impiego del farmaco (Perle cliniche). Il volume è caratterizzato da un tipo di comunicazione verbale-iconico, in cui l’immagine e il testo si completano a vicenda, il che permette una facilità di impiego e una consultazione rapida. Prontuario indispensabile in psicofarmacologia: riassunto aggiornato e completo dei farmaci psicotropi utilizzati in pratica clinica. Un aiuto indispensabile per chiunque prescriva terapie nel campo della salute mentale, facile e schematico da consultare, è corredato di diversi indici. Rispetto alla precedente edizione comprende 11 nuovi composti e fornisce informazioni su diverse nuove formulazioni di farmaci già esistenti. Inoltre, vi sono riportate molte recenti indicazioni importanti dei farmaci già conosciuti. L’intera trattazione è stata aggiornata con le formulazioni iniettabili e transdermiche e con le ultime indicazioni e avvertenze. Adattato alla realtà italiana: nella traduzione sono stati utilizzati alcuni accorgimenti al fine di permettere al lettore di identificare ciò che è specifico nel nostro Paese; i farmaci non disponibili in Italia sono contrassegnati dalla dicitura “ND”, così come sono state controllate le indicazioni approvate nel nostro sistema sanitario (evidenziate in neretto). Unisce i dati basati sull’evidenza alle informazioni terapeutiche incentrate sulla competenza clinica: l’obiettivo dell’Autore è quello di integrare l’arte della pratica clinica con la scienza della psicofarmacologia. Complemento al volume Neuro Psicofarmacologia Essenziale dello stesso Autore (2016), uno dei testi di psicofarmacologia più venduti al mondo.
75,00 66,97

Le pillole più amare. La storia inquietante dei farmaci antipsicotici

Joanna Moncrieff

editore: Giovanni Fioriti Editore

In questo libro la natura rivoluzionaria degli antipsicotici è messa in seria discussione
24,00 22,80

Prescriber's Guide

Stahl's Essential Psychopharmacology

Stephen M. Stahl

editore: Cambridge University Press

pagine: 950

With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present the Seventh Edition of the world's best-selling formulary in psychopharmacology. The new edition features nine new compounds as well as information about several new formulations of existing drugs. Many important new indications are covered for existing drugs, as are updates to the profiles of the entire content and collection, including new injectable and transdermal formulations, as well as updated warnings and indications. The Pearls have all been refreshed and the antipsychotics section has been completely revised. With its easy-to-use, full-colour template-driven navigation system, Prescriber's Guide combines evidence-based data with clinically informed advice to support everyone who is prescribing in the field of mental health.
95,00 90,25

The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry

David M. Taylor, Fiona Gaughran
e altri

editore: Wiley-Blackwell

pagine: 752

Learn to improve your assessment, investigation, and management of physical health conditions in people with severe mental illness The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry offers psychiatric and general practitioners an evidence-based and practical guide for the appropriate assessment, investigation, and management of common physical health conditions seen in people with severe mental illness. Written by a renowned team of respected experts in medicine, surgery, pharmacy, dietetics, physiotherapy, and psychiatry, the book bridges the gap between psychiatric and physical health services for the severely mentally ill. The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry also provides practitioners with expert guidance on making effective referrals to other medical and surgical subspecialties, telling readers what information subspecialties would expect to receive. Its use will improve the quality of clinical care received by mentally ill patients and, by promoting a holistic approach to treatment that considers both body and mind, will enhance the therapeutic relationship between patient and practitioner. The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry covers the following: Guidance on assessment and management of well over a hundred different medical and surgical presentations commonly seen in people with serious mental illness Management of physical health emergencies in a psychiatric setting Evidence-based approaches to management of physical side effects of psychiatric medications Advice on approaches to promote a healthy lifestyle in people with serious mental illness, such as smoking cessation and changes to diet and physical activity Perfect for both psychiatrists and general practitioners who wish to improve the quality of care they provide to people with serious mental illness, The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry will be of use to anyone setting out to navigate the divide between the treatment of psychiatric and physical health conditions.
56,00 53,20

The Maudsley Guidelines on Advanced Prescribing in Psychosis

David M. Taylor, Paul Morrison
e altri

editore: Wiley-Blackwell

pagine: 112

A guide to treating psychosis that provides information on drug options and side-effects in order to allow for weighing treatment options knowledgably The Maudsley Guidelines on Advanced Prescribing in Psychosis offers a resource that puts the focus on the need to treat the individual needs of a patient. The authors – noted experts on the topic – offer an alternative to the one-size-fits-all treatment of psychosis and shows how to build psychiatrist and patient relationships that will lead to effective individual treatment plans. The book provides up-to-date data and information about commonly used anti-psychotic drugs and drugs used in bipolar disorder. The text weighs both the upsides and downsides of each pharmaceutical presented, and helps prescribers and patients weigh the costs and benefits of various options to reach an appropriate treatment plan. The authors highlight the treatment at a population level and the systems in which individual treatments take places. This important resource: Facilitates the tailoring of an appropriate treatment plan for clients manifesting signs of psychosis Offers a comparative strategy that helps gauge the suitability of one treatment plan over another Provides at-hand data and information about commonly used anti-psychotic drugs Includes an understanding of the origins and side-effects of each drug presented The Maudsley Guidelines on Advanced Prescribing in Psychosis offers psychiatrists and other mental health practitioners an essential guide for treating psychosis on an individualized level.
25,00 23,75

Guida all'uso dei farmaci in psichiatria

Luca Pani, Valentina Mantua

editore: Edra

pagine: 436

La Guida all'Uso dei Farmaci in Psichiatria riassume i principi generali di terapia delle principali sindromi psichiatriche, c
24,00 22,80

Schatzberg's Manual of Clinical Psychopharmacology

Alan F. Schatzberg, Charles DeBattista

editore: American Psychiatric Association Publishing

pagine: 836

Schatzberg's Manual of Clinical Psychopharmacology is a meticulously researched, yet down-to-earth guide for practitioners prescribing psychotropic medications to individuals with psychiatric disorders or symptoms mandating treatment. The ninth edition offers up-to-date information on current drugs, interactions, side effects, and dosing guidelines, and retains the strengths and features that have made it a standard text for trainees and practicing clinicians. The authors also include a new chapter on important developments in laboratory-guided pharmacotherapy, including pharmacogenomic testing, neurocognitive testing, quantitative EEG, and neuroimaging. Although the book's primary purpose is to provide the reader-practitioner with basic and practical information regarding the many classes of psychiatric medications, the authors stress that understanding how to select and prescribe psychotropic medications does not obviate the basic need to comprehensively evaluate and understand psychiatric patients. Accordingly, the book draws on the authors' clinical experience, as well as on the scientific literature, resulting in an accessible, yet rigorous text. Features that have helped cement this book's reputation include: • Coverage is not limited to long-standing and newly approved medications, but also includes agents that are likely to receive approval from the FDA in the near future, ensuring that the reader stays up-to-date. • References are provided for key statements, and each chapter is then followed by a list of selected relevant articles and books for readers who want to go beyond the material presented, making for a leaner, more reader-friendly guide. • Dozens of summary tables with key information on classes of psychotropics function as quick-reference guides, promoting learning and serving as convenient resources for overloaded clinicians. • The appendix offers two kinds of suggested readings. The first, for clinicians, is invaluable to trainees, while the second, for patients and families, helps point clinicians to books aimed at a lay audience to supplement information provided to patients. Staying abreast of both new medications and promising treatment protocols is essential in this rapidly evolving field. Schatzberg's Manual of Clinical Psychopharmacology delivers authoritative information in a friendly, collegial style, ensuring that both students and practicing clinicians are equipped to provide a superior standard of care.
120,00 114,00

Clinical Psychopharmacology

Principles and Practice

S. Nassir Ghaemi

editore: Oxford University Press Inc

pagine: 624

Clinical Psychopharmacology offers a comprehensive guide to clinical practice that explores two major aspects of the field: the clinical research that exists to guide clinical practice of psychopharmacology, and the application of that knowledge with attention to the individualized aspects of clinical practice. The text consists of 50 chapters, organized into 6 sections, focusing on disease-modifying effects, non-DSM diagnostic concepts, and essential facts about the most common drugs. This innovative book advocates a scientific and humanistic approach to practice and examines not only the benefits, but also the harms of drugs. Providing a solid foundation of knowledge and a great deal of practical information, this book is a valuable resource for practicing psychiatrists, psychiatric nurse practitioners, medical students and trainees in psychiatry, as well as pharmacists.
94,00 89,30

Inserire il codice per il download.

Inserire il codice per attivare il servizio.